▶ 調査レポート

コラーゲンペプチド&ゼラチンの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Collagen Peptide & Gelatin Market (Product Type: Collagen Peptide and Gelatin; Source: Bovine, Porcine, Poultry, Marine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。コラーゲンペプチド&ゼラチンの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Collagen Peptide & Gelatin Market (Product Type: Collagen Peptide and Gelatin; Source: Bovine, Porcine, Poultry, Marine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2211A108資料のイメージです。• レポートコード:MRC2211A108
• 出版社/出版日:Transparency Market Research / 2022年9月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:食品
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界のコラーゲンペプチド&ゼラチン市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(コラーゲンペプチド、ゼラチン)分析、由来別(牛、豚、家禽、海洋生物、その他)分析、用途別(医薬品、食品・飲料、化粧品、栄養補助食品、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容を掲載しています。なお、当書には、Amicogen、BioCell Technology LLC、Lonza Group Ltd.、Nitta Gelatin, Inc.、GELITA AG、Norland Products, Inc.、Gelnex、Ewald-Gelatine GmbH、Tessenderlo Group NV、Others Prominent Playersなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のコラーゲンペプチド&ゼラチン市場規模:製品別
- コラーゲンペプチドの市場規模
- ゼラチンの市場規模
・世界のコラーゲンペプチド&ゼラチン市場規模:由来別
- 牛由来コラーゲンペプチド&ゼラチンの市場規模
- 豚由来コラーゲンペプチド&ゼラチンの市場規模
- 家禽由来コラーゲンペプチド&ゼラチンの市場規模
- 海洋生物由来コラーゲンペプチド&ゼラチンの市場規模
- その他由来コラーゲンペプチド&ゼラチンの市場規模
・世界のコラーゲンペプチド&ゼラチン市場規模:用途別
- 医薬品における市場規模産業
- 食品・飲料における市場規模産業
- 化粧品における市場規模産業
- 栄養補助食品における市場規模産業
- その他用途における市場規模産業
・世界のコラーゲンペプチド&ゼラチン市場規模:地域別
- 北米のコラーゲンペプチド&ゼラチン市場規模
- ヨーロッパのコラーゲンペプチド&ゼラチン市場規模
- アジア太平洋のコラーゲンペプチド&ゼラチン市場規模
- 中南米のコラーゲンペプチド&ゼラチン市場規模
- 中東・アフリカのコラーゲンペプチド&ゼラチン市場規模
・競争状況

Collagen Peptide and Gelatin Market – Scope of Report

TMR’s report on the global collagen peptide and gelatin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global collagen peptide and gelatin market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global collagen peptide and gelatin market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the collagen peptide and gelatin market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global collagen peptide and gelatin market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global collagen peptide and gelatin market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global collagen peptide and gelatin market.

The report delves into the competitive landscape of the global collagen peptide and gelatin market. Key players operating in the global collagen peptide and gelatin market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global collagen peptide and gelatin market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market collagen peptide and gelatin.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Collagen Peptide and Gelatin Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definitions
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Collagen Peptide and Gelatin Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key product/brand Analysis
5.2. Key Mergers & Acquisitions
5.3. Covid-19 Impact Analysis
6. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Collagen Peptide
6.3.2. Gelatin
6.4. Market Attractiveness Analysis, by Product Type
7. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Source, 2017–2031
7.3.1. Bovine
7.3.2. Porcine
7.3.3. Poultry
7.3.4. Marine
7.3.5. Others
7.4. Market Attractiveness Analysis, by Source
8. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Pharmaceuticals
8.3.2. Food & Beverages
8.3.3. Cosmeceuticals
8.3.4. Nutraceuticals
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Collagen Peptide and Gelatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Collagen Peptide
10.2.2. Gelatin
10.3. Market Value Forecast, by Source, 2017–2031
10.3.1. Bovine
10.3.2. Porcine
10.3.3. Poultry
10.3.4. Marine
10.3.5. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Pharmaceuticals
10.4.2. Food & Beverages
10.4.3. Cosmeceuticals
10.4.4. Nutraceuticals
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Source
10.6.3. By Application
10.6.4. By Country
11. Europe Collagen Peptide and Gelatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Collagen Peptide
11.2.2. Gelatin
11.3. Market Value Forecast, by Source, 2017–2031
11.3.1. Bovine
11.3.2. Porcine
11.3.3. Poultry
11.3.4. Marine
11.3.5. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Pharmaceuticals
11.4.2. Food & Beverages
11.4.3. Cosmeceuticals
11.4.4. Nutraceuticals
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Source
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Collagen Peptide and Gelatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Collagen Peptide
12.2.2. Gelatin
12.3. Market Value Forecast, by Source, 2017–2031
12.3.1. Bovine
12.3.2. Porcine
12.3.3. Poultry
12.3.4. Marine
12.3.5. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Pharmaceuticals
12.4.2. Food & Beverages
12.4.3. Cosmeceuticals
12.4.4. Nutraceuticals
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia and New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Source
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Collagen Peptide and Gelatin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Collagen Peptide
13.2.2. Gelatin
13.3. Market Value Forecast, by Source, 2017–2031
13.3.1. Bovine
13.3.2. Porcine
13.3.3. Poultry
13.3.4. Marine
13.3.5. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Pharmaceuticals
13.4.2. Food & Beverages
13.4.3. Cosmeceuticals
13.4.4. Nutraceuticals
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Source
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Collagen Peptide and Gelatin Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Collagen Peptide
14.2.2. Gelatin
14.3. Market Value Forecast, by Source, 2017–2031
14.3.1. Bovine
14.3.2. Porcine
14.3.3. Poultry
14.3.4. Marine
14.3.5. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Pharmaceuticals
14.4.2. Food & Beverages
14.4.3. Cosmeceuticals
14.4.4. Nutraceuticals
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Source
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Amicogen
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. BioCell Technology LLC
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Lonza Group Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Nitta Gelatin, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. GELITA AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Norland Products, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Gelnex
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Ewald-Gelatine GmbH
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Tessenderlo Group NV
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Others Prominent Players

List of Tables

Table 01: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 02: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 03: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017‒2031

Table 04: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017–2031

Table 05: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 09: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 10: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017‒2031

Table 11: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source 2017–2031

Table 12: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 15: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 16: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017‒2031

Table 17: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017–2031

Table 18: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 21: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 22: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017‒2031

Table 23: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017–2031

Table 24: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 25: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 26: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 27: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 28: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017‒2031

Table 29: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017–2031

Table 30: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 31: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 32: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031

Table 33: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017‒2031

Table 34: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017‒2031

Table 35: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017–2031

Table 36: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017–2031